The world supply of human blood is 4 million units short but the results of a new clinical trial indicate you can bank on the substitute. A phase III multi-center trial was the first to compare the safety and effectiveness of substitute blood and across 46 sites in the United States, Europe and South Africa the bovine sourced, hemoglobin-based oxygen carrier called HBOC-21 did the trick.